Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, Oakes R, Pitts CD.

Am J Psychiatry. 2001 Jun;158(6):906-12.

PMID:
11384898
2.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
3.

Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

Elliott AJ, Uldall KK, Bergam K, Russo J, Claypoole K, Roy-Byrne PP.

Am J Psychiatry. 1998 Mar;155(3):367-72.

PMID:
9501747
4.

Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine.

Chiu HJ, Hong CJ, Chan CH.

Zhonghua Yi Xue Za Zhi (Taipei). 1996 Jun;57(6):418-23.

PMID:
8803304
5.

Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.

Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.

J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72.

6.

Risperidone and paroxetine given singly and in combination for bipolar depression.

Shelton RC, Stahl SM.

J Clin Psychiatry. 2004 Dec;65(12):1715-9.

PMID:
15641878
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.

Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, Geddes J, Gilbody S, Palmer S, Woolacott N.

Health Technol Assess. 2007 Oct;11(39):iii-iv, ix-206. Review.

9.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
10.

Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.

Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR.

Bipolar Disord. 2012 Nov;14(7):780-9. doi: 10.1111/bdi.12013.

11.

Rational polypharmacy in the bipolar affective disorders.

Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.

Epilepsy Res Suppl. 1996;11:153-80. Review.

PMID:
9294735
12.

Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.

Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.

Am J Psychiatry. 2004 Nov;161(11):2060-5.

PMID:
15514407
13.

A double-blind comparison of paroxetine, imipramine, and placebo in major depression.

Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.

J Clin Psychiatry. 1992 Feb;53 Suppl:48-51.

PMID:
1531825
14.
15.

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

Vieta E, T'joen C, McQuade RD, Carson WH Jr, Marcus RN, Sanchez R, Owen R, Nameche L.

Am J Psychiatry. 2008 Oct;165(10):1316-25. doi: 10.1176/appi.ajp.2008.07101560. Epub 2008 Apr 1.

PMID:
18381903
16.

A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators.

J Clin Psychiatry. 2010 Feb;71(2):163-74. doi: 10.4088/JCP.08m04942gre. Epub 2010 Jan 26.

PMID:
20122366
17.

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.

Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J.

J Clin Psychiatry. 2002 Apr;63(4):337-44.

PMID:
12000208
18.

Paroxetine in the treatment of depression: a comparison with imipramine and placebo.

Feighner JP, Boyer WF.

J Clin Psychiatry. 1992 Feb;53 Suppl:44-7.

PMID:
1531824
19.

Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.

Loebel A, Cucchiaro J, Silva R, Kroger H, Sarma K, Xu J, Calabrese JR.

Am J Psychiatry. 2014 Feb;171(2):169-77. doi: 10.1176/appi.ajp.2013.13070985.

PMID:
24170221
20.

Supplemental Content

Support Center